Company Filing History:
Years Active: 2013-2015
Title: Kathy Hodgkinson: Innovator in Cardiomyopathy Diagnostics
Introduction
Kathy Hodgkinson is a prominent inventor based in St. John's, Canada. She has made significant contributions to the field of cardiomyopathy diagnostics, holding 2 patents that focus on innovative methods for diagnosing and treating this serious condition.
Latest Patents
Hodgkinson's latest patents include a diagnostic test for cardiomyopathy. This invention describes methods and compositions related to diagnosing and treating cardiomyopathy, particularly focusing on arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). The patent outlines methods for screening, diagnosing, or detecting a risk of developing ARVD/C by identifying the presence of a transmembrane protein 43 (TMEM43) disease-associated variant in a subject's sample. The presence of this variant indicates that the subject has ARVD/C or an increased risk of developing it compared to individuals with wild-type TMEM43.
Career Highlights
Throughout her career, Kathy Hodgkinson has worked with notable organizations, including Genesis Group Inc. and Memorial University of Newfoundland. Her work has significantly impacted the understanding and treatment of cardiomyopathy.
Collaborations
Some of her notable coworkers include Terry-Lynn Young and Sean Connors, who have contributed to her research and innovations in the field.
Conclusion
Kathy Hodgkinson's work in cardiomyopathy diagnostics exemplifies her dedication to advancing medical science. Her innovative patents and collaborations highlight her role as a key figure in this important area of research.